BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/15/2025 9:46:09 AM | Browse: 62 | Download: 243
 |
Received |
|
2025-09-26 03:35 |
|
Peer-Review Started |
|
2025-09-26 08:41 |
|
First Decision by Editorial Office Director |
|
2025-10-21 06:29 |
|
Return for Revision |
|
2025-10-21 06:29 |
|
Revised |
|
2025-10-30 13:33 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-12 02:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-12 07:44 |
|
Articles in Press |
|
2025-11-12 07:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-03 00:27 |
|
Publish the Manuscript Online |
|
2025-12-15 09:46 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Zhejiang University index predicts metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Man Zhang, Miao-Guang Yu, Xiang-Nan Shen and Guo-Bin Kang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guo-Bin Kang, Academic Fellow, Department of Cardiology 1, Hebei Provincial Hospital of Chinese Medicine/The First Affiliated Hospital of Hebei University of Chinese Medicine, The First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang, 050000, China. Electronic address: kanggb1229@126.com, Shijiazhuang 050000, Hebei, China. kanggb1229@126.com |
| Key Words |
Zhejiang University index; Metabolic dysfunction-associated steatotic liver disease; Type 2 diabetes mellitus; Predictive biomarker; Cross-sectional study; Pharmacotherapy confounding |
| Core Tip |
This correspondence critically evaluates the study by Tao et al on the ability of the Zhejiang University index to predict metabolic dysfunction-associated steatotic liver disease (MASLD) in type 2 diabetes mellitus patients. It commends the index as it is a minimally invasive biomarker panel and methodologically sound but highlights several limitations, such as the reliance on a hospitalized patient sample, lack of information on pharmacological treatments, the inherent constraints of ultrasound imaging, and the cross-sectional nature of the study. The authors suggest that future research should aim at prospective validation in outpatient settings and exploring the underlying mechanisms of MASLD. |
| Publish Date |
2025-12-15 09:46 |
| Citation |
Zhang M, Yu MG, Shen XN, Kang GB. Zhejiang University index predicts metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients. World J Diabetes 2025; 16(12): 114565 |
| URL |
https://www.wjgnet.com/1948-9358/full/v16/i12/114565.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v16.i12.114565 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
